The concept is striking because chronological age and biological age are not always the same. Chronological age is simply the number of years a person has lived, while biological age reflects the condition and functioning of cells and tissues. Scientists estimate biological age using molecular markers, including epigenetic changes. These changes do not alter the DNA sequence itself. Instead, they influence how genes are switched on or off, often through chemical modifications such as DNA methylation, in which small molecular groups attach to specific regions of DNA.

DNA methylation patterns change across the lifespan in partly predictable ways. By examining these patterns, researchers can calculate an epigenetic age estimate and compare it with a person’s actual age. When the estimated biological age is higher than the chronological age, researchers may describe the difference as accelerated or premature epigenetic aging. This does not mean that an individual is inevitably destined to develop disease early, but it may indicate that the body has been exposed to biological processes associated with faster aging.

The new research focuses on young adulthood, a period when the brain is still undergoing important structural and functional refinement. Although childhood and adolescence are often considered the central stages of brain development, neural maturation continues into the twenties. During this period, the brain reorganizes connections between regions, improves the efficiency of communication networks, and strengthens systems involved in planning, attention, working memory, decision-making and emotional regulation.

Pelant and colleagues examined the relationship between epigenetic aging and deviations from normative brain development. Normative modeling is a statistical approach that estimates how an individual’s brain compares with expected patterns observed across a reference population. Instead of asking only whether a brain measure is high or low, this method can identify whether a person’s brain structure or function falls outside the typical range for their age. Such deviations may reveal subtle differences that would be missed by conventional group comparisons.

According to the study’s focus, young adults with signs of premature epigenetic aging also showed differences in brain development relative to normative expectations. The findings suggest that accelerated biological aging may be reflected not only in molecular measurements taken from the body, but also in the way the brain’s development is organized. However, the relationship should not be interpreted as proof that epigenetic aging directly causes altered brain development. The study is examining associations, and many biological, psychological, environmental and lifestyle factors may influence both outcomes.

The researchers also investigated cognitive performance, bringing the findings closer to questions that matter in everyday life. Cognitive abilities depend on distributed networks rather than a single brain region. Attention, memory, processing speed and executive functions emerge from the coordinated activity of multiple systems. If brain development deviates from age-related expectations, those differences may be associated with measurable variation in how efficiently a person performs cognitive tasks. The study therefore adds a functional dimension to the molecular and neuroimaging evidence.

The implications are potentially significant because young adulthood is often viewed as a period of peak health, yet it may already contain detectable differences in biological aging. If epigenetic measures, brain-based normative models and cognitive testing can be combined reliably, scientists may eventually develop more sensitive ways to identify individuals whose development is progressing along an atypical trajectory. Such tools could support earlier research into prevention and could help clarify how stress, sleep, nutrition, physical activity, mental health and other exposures interact with biological aging.

At the same time, the findings should be understood as an emerging piece of evidence rather than a diagnostic test or a prediction of an individual’s future. Epigenetic clocks can vary according to the tissues analyzed, the molecular algorithms used and the population in which they were developed. Brain measurements are also influenced by technical factors, and cognitive scores can change with education, motivation, fatigue and testing conditions. Long-term studies will be needed to determine whether premature epigenetic aging and atypical brain development persist over time, whether they can be modified, and how strongly they predict later health or cognitive outcomes.

The study’s broader message is that aging may begin as a subtle, multidimensional process long before visible symptoms appear. Molecular biology, brain imaging and cognitive science are increasingly being combined to map that process in greater detail. By linking epigenetic age with brain-development patterns and performance in young adults, the research opens a provocative window onto why people of the same chronological age can differ biologically—and why those differences may matter for the brain.

Subject of Research: Premature epigenetic aging, normative brain development, and cognitive performance in young adulthood

Article Title: Premature epigenetic aging, deviations from normative brain development, and cognitive performance in young adulthood

Article References: Pelant, L., Marecek, R., Pačínková, A. et al. “Premature epigenetic aging, deviations from normative brain development, and cognitive performance in young adulthood.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04337-3

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04337-3

Keywords: epigenetic aging, biological age, brain development, normative modeling, cognitive performance, young adulthood, DNA methylation, neuroscience, Translational Psychiatry

The research, led by Dr. Hagit Masika under the supervision of Professors Howard Cedar and Tommy Kaplan at the Hebrew University of Jerusalem, was conducted in collaboration with Professor Wolf Reik of Altos Labs and the Babraham Institute in Cambridge. The investigators examined individual cells from multiple mouse and human tissues instead of relying primarily on measurements from entire tissue samples. This distinction was crucial because conventional tissue-level analysis averages molecular signals across millions of cells, potentially concealing small groups that are aging unusually quickly.

The team focused on DNA methylation, an epigenetic process that helps regulate gene activity. In this process, chemical groups called methyl groups are added to DNA, often at sites where cytosine is followed by guanine, known as CpG sites. Patterns of methylation change throughout life and can serve as biological clocks, providing an estimate of a cell’s biological age that may differ from its chronological age. The researchers paid particular attention to the gain of methylation at polycomb CpG islands, genomic regions associated with developmental regulation and the activity of Polycomb group proteins.

When methylation data were analyzed at single-cell resolution, aging-related variation became clearly visible. Cells from the same tissue and organism did not progress through epigenetic aging at a uniform rate. Instead, the researchers observed a broad distribution of biological ages, with most cells following a relatively gradual trajectory and a smaller subset showing markedly advanced methylation patterns. This accelerated group appeared to contribute disproportionately to the increasing variation between cells observed in older tissues.

The study also identified a connection between cellular proliferation and accelerated epigenetic aging. Rapidly dividing cells were more likely to display the molecular signature associated with faster aging. Each round of cell division requires the genome to be copied and its regulatory landscape to be restored, creating opportunities for errors or incomplete maintenance of epigenetic information. Repeated proliferation may therefore increase the likelihood that a cell will accumulate abnormal methylation, particularly at regulatory regions that are normally protected from inappropriate silencing.

The biological consequences of this process may extend beyond the methylation clock itself. Cells with advanced epigenetic ages showed altered activity in genes involved in immune responses, protein production, neurodegeneration, and tumor development. These changes do not prove that accelerated methylation directly causes disease, but they indicate that cells with older molecular profiles may also be functionally distinct. A small population of unusually aged cells could therefore influence tissue behavior, weaken local repair mechanisms, or create conditions that allow abnormal cells to survive and expand.

One of the study’s most visually striking observations came from hair. The investigators compared black and white hairs collected from the same individual and found that white hairs consistently carried an older epigenetic signature. Because neighboring hair follicles can experience similar systemic conditions while producing different pigmentation outcomes, the result provides an accessible example of how biological aging can diverge at the level of individual structures. It also supports the idea that visible age-related traits may reflect local cellular histories rather than a single aging rate imposed uniformly across the entire body.

The researchers emphasize that increasing cellular heterogeneity is not universal across all tissues. Some organs and cell populations may age in a comparatively uniform manner, while others become increasingly diverse with age. Differences in cell turnover, exposure to inflammation, metabolic demands, stem-cell activity, and tissue architecture could determine which aging pattern emerges. The findings therefore challenge the idea of a single biological clock governing the whole organism and instead point toward multiple, tissue-specific aging processes that operate simultaneously.

By identifying individual cells that appear to enter an accelerated aging state, the study could influence how scientists investigate cancer, neurodegeneration, and other age-related disorders. Future research may determine whether these cells are causes, consequences, or both of tissue decline, and whether their molecular state can be slowed or reversed. Single-cell epigenetic profiling could eventually help reveal the earliest cellular changes preceding disease, allowing researchers to distinguish vulnerable cells from those that remain resilient. For now, the central message is clear: aging is not a synchronized march shared equally by every cell, but a gradual divergence in which some cells move into biological old age long before their neighbors.

Subject of Research: Cells

Article Title: Cell-to-cell variability and gain of methylation at polycomb CpG islands as a hallmark of aging

News Publication Date: 9-Jun-2026

Web References: https://doi.org/10.1038/s41467-026-74118-5

References: Nature Communications, DOI: 10.1038/s41467-026-74118-5

Keywords: Aging, biological age, epigenetics, DNA methylation, single-cell analysis, polycomb CpG islands, cellular heterogeneity, cancer, neurodegeneration, genomics

At the heart of this breakthrough lies the integration of two complex biological data sets: the IgG N-glycome and the blood transcriptome. The IgG N-glycome pertains to the intricate sugar structures covalently attached to immunoglobulin G (IgG) antibodies. These glycan modifications play key roles in immune function and have been shown to evolve with age, reflecting immune system remodeling and systemic physiological changes. On the other hand, the transcriptome captures a snapshot of active gene expression within blood cells at any given moment, offering a dynamic overview of cellular activity and responses to internal and external stimuli. By examining these two layers together, the researchers aimed to encapsulate a more holistic fingerprint of biological aging.

Developing a tool capable of synergizing these complex data types was a formidable challenge, expertly addressed through the application of Deep Reinforcement Learning, a sophisticated form of artificial intelligence where algorithms iteratively learn optimal decision-making strategies from interacting with the data environment. This approach led to the creation of an ageing clock dubbed “gtAge,” a model that comprehensively interprets multi-omics inputs to predict biological age. Dr Xingang Li, a leading co-author and Postdoctoral Research Fellow at ECU, elucidated that gtAge can predict chronological age with a remarkable 85.3% accuracy, substantially surpassing previous models that relied solely on either glycomic or transcriptomic data.

The implications of this enhanced precision are profound. The model calculates what is known as the “delta age,” the discrepancy between predicted biological age and actual chronological age. This delta age correlates significantly with well-established markers of health and aging, including cholesterol levels, glucose metabolism, and other cardiovascular and metabolic indicators. Such linkage suggests that gtAge not only measures aging but also provides an actionable metric related to an individual’s real health risks, offering a potential early diagnostic tool for age-associated diseases.

Dr Li highlighted the critical limitation of relying exclusively on chronological age, pointing out its inability to capture the heterogeneity in aging observed across individuals. While some people experience pronounced physical and cognitive decline in their 60s or 70s, others maintain robust health well into nonagenarian years. This variation is attributable to differences in biological age driven by genetics, lifestyle, nutritional status, and disease history, emphasizing the need for a metric like gtAge that reflects these nuanced factors.

The development of gtAge also underscores a triumph of interdisciplinary collaboration. ECU’s Dr Syed Islam, a Senior Lecturer in Computer Science, led the AI methodology. His team engineered a custom AI tool named “AlphaSnake,” which harnesses Deep Reinforcement Learning to intelligently select the most informative features from the multi-omics datasets, avoiding the traditional pitfalls of naïvely merging heterogeneous data. The algorithm effectively navigates the complex biological landscape, balancing signal extraction while minimizing noise and redundancy, thus optimizing the age prediction model.

Testing the model rigorously, the researchers applied gtAge to a cohort of 302 middle-aged adults participating in the Busselton Healthy Ageing Study in Western Australia. This study population provided a valuable landscape to evaluate the tool’s robustness across a typical demographic range. Findings demonstrated that gtAge not only reflected chronological age with high fidelity but also linked with biological markers indicative of health status, reinforcing its potential clinical utility.

In context, Australia’s population dynamics—marked by rising elderly demographics—amplify the relevance of such a tool. The ability to assess biological age precisely allows healthcare practitioners to identify patients at elevated risk of age-dependent disorders earlier, enabling timely intervention strategies that could delay or prevent disease onset. Dr Islam emphasized the prospective public health benefits, where early lifestyle modifications informed by biological age measurements could markedly improve quality of life and reduce healthcare burdens.

Importantly, the concept of an aging clock is not new, yet previous iterations struggled with limited accuracy, often due to reliance on single data types or insufficient integration methods. The gtAge clock sets a new benchmark by leveraging multi-omics integration facilitated through a novel AI framework, thus providing a richer, more accurate picture of aging biology that captures the multifaceted nature of the process.

Beyond predicting age, this multifactorial approach opens the door for uncovering mechanisms that drive aging at a molecular level. The integration of glycomic and transcriptomic data provides insights into immune modulation, inflammatory status, and genetic regulation affecting aging pathways. Such mechanistic understanding could inform drug discovery, therapeutic targeting, and the design of personalized anti-aging interventions.

Looking forward, the research team envisions expanding the utility of gtAge through larger, more diverse population studies and longitudinal tracking to monitor how biological age changes over time in response to interventions. This could enrich its predictive power and verify its role as a dynamic health biomarker. Furthermore, integrating additional omics layers, such as proteomics or metabolomics, may refine and enhance the model’s sensitivity and specificity.

The study detailing this advance, titled “Deep Reinforcement Learning–Driven Multi-Omics Integration for Constructing gtAge: A Novel Aging Clock from IgG N-glycome and Blood Transcriptome,” was published in the journal Engineering on August 19, 2025. The authors’ transparent declaration asserts no competing financial interests, affirming the integrity of their findings.

In summary, this transformative work represents a milestone in aging research and precision medicine. As technologies converge and sophisticated AI models emerge, tools like gtAge provide an empowering lens for clinicians and individuals alike to understand biological aging beyond the passage of time. By translating complex biological data into meaningful health insights, this innovation holds the promise of fostering healthier lifespans and reshaping ageing from an inevitable decline to a manageable, informed journey.

Subject of Research: Cells

Article Title: Deep Reinforcement Learning–Driven Multi-Omics Integration for Constructing gtAge: A Novel Aging Clock from IgG N-glycome and Blood Transcriptome

News Publication Date: 19-Aug-2025

Web References:
https://www.sciencedirect.com/science/article/pii/S2095809925004837?via%3Dihub
http://dx.doi.org/10.1016/j.eng.2025.08.016

References:
Li, X., Islam, S., Xia, Y., Baten, A., Tan, X., & Wang, W. (2025). Deep Reinforcement Learning–Driven Multi-Omics Integration for Constructing gtAge: A Novel Aging Clock from IgG N-glycome and Blood Transcriptome. Engineering. https://doi.org/10.1016/j.eng.2025.08.016

Keywords:
Biological age, Aging clock, IgG N-glycome, Blood transcriptome, Deep reinforcement learning, Multi-omics integration, Artificial intelligence, Machine learning, Precision medicine, Age-related diseases

The Clock Drawing Test has long been recognized as a simple yet effective tool to assess cognitive domains including memory, executive function, spatial abilities, and motor coordination. The digital adaptation (dCDT) offers enhanced precision and automation, delivering scores that quantify specific cognitive skills rather than a generalized outcome. By applying these measures within the framework of the Framingham Heart Study, the current research investigates whether molecular signatures of aging, particularly epigenetic modifications, can predict subtle cognitive changes before clinical symptoms manifest.

Epigenetic age acceleration is computed by examining DNAm patterns—chemical tags that regulate gene expression without altering the underlying DNA sequence. With age, DNAm profiles shift, reflecting accumulated molecular damage, exposure to environmental factors, and lifestyle influences. The acceleration metric captures the discrepancy between biological and chronological age, thus serving as a proxy for an individual’s “true” physiological aging rate. This study specifically assessed multiple established epigenetic clocks, including Horvath, PhenoAge, DunedinPACE, and GrimAge, each representing distinct facets of molecular aging.

A remarkable sample of 1,789 individuals drawn from the Framingham cohort provided the data pool, enabling the scientists to correlate biological age acceleration with subsequent dCDT performance recorded approximately seven years later. Statistically controlling for confounding variables such as baseline chronological age, sex, educational background, and blood cell composition, the researchers observed a compelling inverse association between DNAm age acceleration and dCDT scores. Notably, this relationship was most pronounced in participants aged 65 and older, underscoring potential age-dependent vulnerabilities in brain aging.

Among the epigenetic clocks analyzed, the DunedinPACE measure stood out as the most robust predictor of diminished cognitive performance in both younger and older adults. This finding suggests that this speedometer of aging not only marks age-related biological deterioration but also aligns closely with declines in neurological functions. Conversely, other clocks like Horvath and PhenoAge demonstrated significant cognitive associations primarily within the older population, implying their sensitivity to accumulated epigenetic changes manifesting in late life cognitive deficits.

The research further explored the influence of aging-related plasma proteins encapsulated within the GrimAge clock, specifically focusing on two markers: Plasminogen Activator Inhibitor-1 (PAI1) and Adrenomedullin (ADM). Elevated levels of these proteins, correlated with systemic aging and inflammation, were linked to poorer cognitive outcomes, particularly among senior participants. These protein biomarkers reinforce the concept that cognitive decline is not an isolated cerebral phenomenon but a reflection of systemic biological aging affecting multiple organ systems.

With the epigenetic clocks and protein markers collectively illustrating a molecular portrait of cognitive aging, the study presents a compelling case for the integrative monitoring of brain health. Digital cognitive testing tools like the dCDT, when paired with molecular assays of DNAm and plasma proteins, could usher in a new era of personalized aging diagnostics. Clinicians might one day utilize these combined biomarkers to detect early cognitive impairment, enabling timely intervention strategies long before overt dementia surfaces.

The mechanistic underpinnings remain a focus of ongoing research, but these epigenetic patterns likely reflect cumulative oxidative stress, chronic inflammation, and diminished cellular repair mechanisms—all processes intricately linked to neurodegenerative disease pathogenesis. Moreover, the heterogeneous associations across different epigenetic clocks reinforce the multifaceted nature of aging biology and the necessity for a composite biomarker approach rather than reliance on a single molecular indicator.

Figurative heatmaps presented in the original publication illuminate the nuanced relationships between standardized DNAm age acceleration increments and specific cognitive domains measured by the dCDT, such as spatial reasoning and motor skill execution. The P-values embedded within reveal the statistical weight of these associations, reaffirming their robustness despite adjustments for confounders. This graphical representation accentuates the precise cognitive functions most susceptible to biological aging effects, further refining potential targets for neuroprotective therapies.

The implications of this study extend beyond the realm of cognitive neuroscience and gerontology into public health and aging-related policy. Aging populations worldwide face burgeoning burdens of dementia and cognitive impairment, demanding innovative screening modalities capable of rapid, scalable deployment. The dCDT’s automated digital format combined with non-invasive blood-based epigenetic profiling presents a viable path forward, marrying technological accessibility with molecular sophistication.

Moreover, these findings challenge the long-standing primacy of chronological age in assessing brain health. By revealing how a person’s biological aging rate may diverge significantly from their chronological years, the study advocates for a paradigm shift toward more nuanced and individualized aging assessments. This molecular approach holds promise not only for early diagnosis but also for monitoring therapeutic responses and lifestyle interventions aimed at decelerating biological aging trajectories.

Ethical and practical considerations accompany the integration of these biomarkers into clinical and research settings. Issues concerning data privacy, equitable access, and interpretation of epigenetic data in diverse populations necessitate careful deliberation. Nonetheless, the clear associations established between DNAm age acceleration and cognitive decline underscore the urgency of advancing this field toward translational applications.

In summary, the Boston University-led team’s pioneering work within the longstanding framework of the Framingham Heart Study provides critical empirical evidence linking DNA methylation-based biological age acceleration with subsequent cognitive decline measured via the digital Clock Drawing Test. This convergence of epigenetic science and digital cognitive assessment heralds transformative possibilities in aging research and clinical practice, illuminating pathways to detect, track, and perhaps ultimately mitigate the ravages of cognitive aging.

Subject of Research: Not explicitly specified beyond research on molecular and cognitive aging.

Article Title: Association of DNA methylation age acceleration with digital clock drawing test performance: the Framingham Heart Study

News Publication Date: 21-Jul-2025

Web References:

• https://www.aging-us.com/issue/v17i7
• http://dx.doi.org/10.18632/aging.206285

Image Credits: © 2025 Li et al., licensed under Creative Commons Attribution License (CC BY 4.0)

Keywords: aging, epigenetic aging, DNA methylation, cognitive function, digital Clock Drawing Test